Impinj, Inc. (LON:0J9J)

Revance Therapeutics Revenue

Impinj had revenue of $74.28M USD in the quarter ending March 31, 2025, a decrease of -3.32%. This brings the company's revenue in the last twelve months to $363.54M, up 21.80% year-over-year. In the year 2024, Impinj had annual revenue of $366.09M with 19.04% growth.

• Revenue (ttm): $363.54M
• Revenue Growth: +21.80%
• P/S Ratio: 12.82
• Revenue / Employee: $806.07K
• Employees: 451
• Market Cap: 3.36B

Revenue Chart

* This company reports financials in USD.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	366.09M	58.55M	19.04%
Dec 31, 2023	307.54M	49.74M	19.29%
Dec 31, 2022	257.80M	67.52M	35.48%
Dec 31, 2021	190.28M	51.36M	36.97%
Dec 31, 2020	138.92M	-13.91M	-9.10%